Logo Lucerna-Chem
+41 41 420 9636

Regulatory Status

Article Status


KCC-07


Catalog Number Pack Size List Price* Promo Price* Quantity
HY-131031-5MG 5 mg 102,00 86,70 Add
HY-131031-10MG 10 mg 181,00 153,90 Add
HY-131031-25MG 25 mg 358,00 304,30 Add
HY-131031-50MG 50 mg 573,00 487,10 Add
HY-131031-100MG 100 mg 894,00 759,90 Add

* CHF, excl. 7.7% VAT and shipping costs


Product Description

KCC-07 is a potent, selective and brain-penetrant MBD2 (methyl-CpG-binding domain protein 2) inhibitor. KCC-07 prevents binding of MBD2 to methylated DNA and activates brain specific angiogenesis inhibitor 1 (BAI1) inducing anti-proliferative BAI1/p53/p21 signaling. Anticancer activity.

Category Biochemicals
Supplier MedChem Express
Application Cancer-programmed cell death
Regulatory Status RUO
Format Solubility: DMSO : 250 mg/mL (928.26 mM; Need ultrasonic)
Grade Clinical information: No Development Reported
Purity 99.26%
Molecular Formula C14H11N3OS
Molecular Weight 269.32
CAS-Number [315702-75-1]
Storage Conditions 4°C, protect from light; In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
Product Line Research
Tech. Data Sheet View datasheet
Link To Supplier http://www.medchemexpress.com
Material Safety Data Sheet Download PDF
Call us

Customer Support
T +41 41 420 96 36
F +41 41 420 96 56
info@lucerna-chem.ch

Business Hours
From Monday through Friday
08:00 – 12:00
13:00 – 17:00

Ask us

Technical Support
tech@lucerna-chem.ch

Business Development
business.dev@lucerna-chem.ch

Postal address
Lucerna-Chem AG
Abendweg 18
CH-6006 Luzern

Newsletter













If you have already subscribed to our newsletter and would like to update your details or cancel it, please click here.


© Copyright 2021 Lucerna-Chem AG, Switzerland